1A9bnbK
1A9bnbK
1A9bnbK
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
***<br />
THE DISEASES − CHAPTER 4<br />
101<br />
Investment case<br />
Yaws is a disabling and disfiguring disease that “begins where the road ends” – among<br />
the poorest and most isolated communities. It is targeted by WHO for eradication by<br />
2020 but the global campaign is not yet financed.<br />
It has been estimated that a global yaws eradication campaign could be established with new<br />
investments of as little as US$ 100 million in the 12 known endemic countries, provided<br />
that the necessary medicines are donated. 1 The full economic cost including medicines<br />
(yet to be donated) and existing Ministry of Health staff and assets would be higher (as<br />
depicted in Chapter 2, Fig. 2.4). Even with these economic costs, however, eradication<br />
would cost only US$ 26 (4.2–78) for each additional year of life lived without disability or<br />
disfigurement due to yaws.<br />
The cost of the “end game” of any eradication effort is uncertain, with the emergence of<br />
complexities requiring some local adaptation of global strategies. Much of the uncertainty<br />
will be resolved as endemic countries implement the programme. In any case, under<br />
most reasonable assumptions, a global eradication campaign will be highly cost–effective.<br />
Importantly, from the perspective of universal health coverage, it will benefit some of the<br />
world’s least well off citizens. Eradication of this neglected disease of poverty can be seen<br />
as complementary to universal health coverage and shared prosperity on the post-2015<br />
development agenda.<br />
There is less evidence to estimate investments for the control of bejel or pinta. Investment<br />
targets for these diseases may be added in future updates to the analyses of this report.<br />
_____________________<br />
1<br />
Fitzpatrick C, Asiedu K, Jannin J. Where the road ends, yaws begins? The cost effectiveness of eradication versus more<br />
roads. PLoS Negl Trop Dis. 2014;8:e3165. doi:10.1371/journal.pntd.0003165.<br />
Burden and distribution<br />
The global burden of endemic treponematoses is not known accurately. Fig. 4.6.1 and<br />
Fig. 4.6.2 show the most recent (2013) data, based on routine surveillance and surveys from<br />
some countries. Since reporting of yaws is not mandatory, these figures are only indicative of<br />
the distribution of the disease. However, with the eradication of yaws by 2020 in mind, it will<br />
be essential to make its reporting mandatory.